Data from the PARTIQoL trial show no significant difference in progression-free survival, bowel function, and other patient quality-of-life measures between PBT and IMRT. Proton beam therapy (PBT) and ...
"When determining which code you should use, you must consider your Medicare carrier’s published rules and commercial payer processing policies," write Jonathan Rubenstein, MD, and Mark Painter. The ...
A late-breaking abstract at ASTRO 2024 shows local therapy history does not significantly affect the risk of death in patients with mCRPC receiving an ARPI. The treatment effects of first-line ...
"The landscape of prostate cancer management has evolved significantly over the past 30 years, with [active surveillance], advances in imaging and genetics, and improvements in the treatment of ...
Radiation therapy is linked to improved 5-year survival rates when used to target both the primary tumor and metastatic lesions (total consolidative therapy [TCT]) in patients with oligometastatic ...
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility. The recommendation for lower the sperm concentration ...
In August 2024, the FDA granted 510(k) clearance to the HYDROS robotic system, an AI-powered platform designed to enhance the delivery of Aquablation therapy for patients with benign prostatic ...
Ga-68 PSMA-11 radiotracer may be a feasible option for SCINTIX radiation therapy in patients whose prostate cancer has spread to the bones. Gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) ...
New CEASAR findings at ASTRO 2024 show how 3 treatment modalities differ in prostate cancer patient functioning—as well as how patients perceive the issues. Approximately one-third of men to receive ...
"The landscape of prostate cancer management has evolved significantly over the past 30 years, with [active surveillance], advances in imaging and genetics, and improvements in the treatment of ...
"As we expected, the MRIs with contrast were far more expensive," says Benjamin Pockros, MD, MBA. In this video, Benjamin Pockros, MD, MBA, discusses the Urology Practice paper “Financial Implications ...
"This exciting and innovative technology has a wide range of possible applications, including tissue engineering, drug development, and precision medicine," write Kate Gessner, MD, PhD, and Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback